<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04640558</url>
  </required_header>
  <id_info>
    <org_study_id>KarsSH</org_study_id>
    <nct_id>NCT04640558</nct_id>
  </id_info>
  <brief_title>Gluteus Medius Latent Trigger Point and Muscle Strength in Healthy Subjects</brief_title>
  <official_title>The Relationship Between Gluteus Medius Latent Trigger Point and Muscle Strength in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kars State Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kars State Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to investigate the relationship between latent MTrPs and gluteus medius&#xD;
      muscle strength in a group of healthy adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Latent myofascial trigger points (MTrPs) do not cause spontaneous pain; however, they may&#xD;
      lead to a limited range of motion and muscle weakness. We hypothesized that latent MTrPs&#xD;
      might decrease gluteus medius muscle strength in healthy individuals. Forty-eight healthy men&#xD;
      will be included in the study. Trigger point examination for the gluteus medius will be&#xD;
      performed bilaterally. Subjects with one or more trigger points on the dominant side and&#xD;
      those without any trigger points will be assigned to two groups. Muscle strength for gluteus&#xD;
      medius will be assessed with a manual muscle tester using the &quot;break test&quot; technique on both&#xD;
      sides. The subjects and the examiners will be blinded. For statistical analysis, the&#xD;
      independent sample t-test was used to compare the intergroup differences.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 17, 2020</start_date>
  <completion_date type="Actual">January 17, 2021</completion_date>
  <primary_completion_date type="Actual">January 17, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>4 Weeks</target_duration>
  <primary_outcome>
    <measure>Gluteus medius muscle strength</measure>
    <time_frame>One month</time_frame>
    <description>In the participant's side-lying position, the practitioner will be applied resistance from the upper ankle to the abduction movement with slight flexion of the upper hip. During the measurements, the participants will be asked to perform the maximum isometric contraction for 3 seconds. Gluteus medius muscle strength measurements will be repeated three times, one minute apart, on the right and left sides. The mean of the measurements will be calculated and recorded</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">48</enrollment>
  <condition>Myofascial Pain Syndrome</condition>
  <condition>Muscle Weakness</condition>
  <arm_group>
    <arm_group_label>Group 1. Latent Myofascial Trigger Point Group</arm_group_label>
    <description>24 participants who will be clinically diagnosed with unilateral latent myofascial trigger point in the dominant side gluteus medius muscle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2. Non-Latent Myofascial Trigger Point Group</arm_group_label>
    <description>24 participants who don't have latent myofascial trigger point.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Muscle strength measurement</intervention_name>
    <description>The bilateral gluteus medius muscle strength of each participant will be measured by the assessor (MB) blinded to the participants using the Lafayette manual muscle tester. (Lafayette Instrument Company, Lafayette IN, USA). In the participant's side-lying position, the practitioner applied resistance from the upper ankle to the abduction movement with slight flexion of the upper hip. During the measurements, the participants were asked to perform the maximum isometric contraction for 3 seconds. Gluteus medius muscle strength measurements were repeated three times, one minute apart, on the right and left sides. The mean of the measurements was calculated and recorded</description>
    <arm_group_label>Group 1. Latent Myofascial Trigger Point Group</arm_group_label>
    <arm_group_label>Group 2. Non-Latent Myofascial Trigger Point Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        24 participants who are clinically diagnosed with unilateral latent MTrP in the dominant&#xD;
        side gluteus medius muscle and 24 participants who don't have latent MTrP.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient age: 18-40 years.&#xD;
&#xD;
          -  Absence of musculoskeletal complaints related to the lumbar, sacroiliac, and hip area.&#xD;
&#xD;
          -  Absence of bilateral latent MTrP in the gluteus medius muscle.&#xD;
&#xD;
          -  Latent trigger point in the gluteus medius muscle on the dominant side with palpation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A history of medical treatment, physical therapy, injection therapy, or surgical&#xD;
             treatment related to the lumbar, sacroiliac, and hip area.&#xD;
&#xD;
          -  History of trauma, or malignancy or being pregnant, or if the patient is in the&#xD;
             lactation period.&#xD;
&#xD;
          -  Bilateral latent MTrP in the gluteus medius muscle.&#xD;
&#xD;
          -  Presence of latent MTrP on the non-dominant side.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Biruni University Faculty of Medicine</name>
      <address>
        <city>Ä°stanbul</city>
        <zip>34100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 17, 2020</study_first_submitted>
  <study_first_submitted_qc>November 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2020</study_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kars State Hospital</investigator_affiliation>
    <investigator_full_name>Fatih Bagcier</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Trigger point</keyword>
  <keyword>Gluteus medius muscle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
    <mesh_term>Fibromyalgia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

